Netflix, Inc. NFLX – Options -We signaled a range of options contracts on NFLX in yesterday’s premarket report, citing the earnings beat of the previous afternoon. We specifically mentioned that we were looking out for a dip-and-rip formation on the chart and the stock produced a classic example of such. NFLX’s big day, which ultimately facilitated those multi-bag profit opportunities, was fueled by an impressive 5 million new subscribers to the Netflix streaming service.
Right out of the gate, it dipped briefly to the high $175 area before going on an hours-long bullish push to the upper $184′s. That activity led to some really nice gains in our highlighted options, the NFLX Weekly $172.50-180 Calls:
$172.50 Calls – Range: 3.80-12.75 – Max Gain: 236%
$175 Calls – Range: 2.50-10.50 – Max Gain: 320%
$177.50 Calls – Range: 1.40-8.30– Max Gain: 493%
$180 Calls – Range: .85-6.42 – Max Gain: 655%
Nutanix, Inc. NTNX – We also want to circle back to recap the moves made by an options idea we included in Friday morning’s report. NTNX continued to climb yesterday, and so the NTNX 7/21 $20-25 Calls we signaled have turned up some really nice moves.
$20 Calls – Range: 1.65-3.90 – Max Gain: 136%
$22.50 Calls – Range: .40-1.56 – Max Gain: 290%
$25 Calls – Range: .05-.28 – Max Gain: 460%
We also had a number of the stocks that we highlighted in yesterday’s report yield chances for solid gains, and of them gave us a reason to look out for further moves:
Caprico Therapeutics, Inc. CAPR - The biggest gainer of the day from our mentions and on the NASDAQ itself, CAPR traded in a range from a low of .901, on up to a high of 1.62. That worked out to an 80% rip, and it came on an incredible 291X the monthly average volume.
The huge session was catalyzed by the announcement that the FDA has granted Rare Pediatric Disease Designation to CAP-1002, Capricor’s development candidate for the treatment of Duchenne muscular dystrophy. (>>View PR)
Marijuana Company of America, Inc. MCOA - There was a nice move in MCOA as the stock traded up 38% from .02685-.037 on close to five times its monthly average volume, and the table may be set for a continuation of the trend with a new PR hitting the wires this morning.
The company is reporting that it has received the first round of funding for a joint venture to construct a 30,000 sq. ft. greenhouse grow facility in Oroville, Washington. Once completed, the greenhouse facility will accommodate a cannabis production and processing tenant with a Tier 3, I-502 license… (>>View PR)
Novavax Inc. NVAX - This one recorded a very respectable gain on the day, running steadily from 1.17 up to 1.53, a 31% upswing. More importantly, the stock maintained the vast majority of its daily advance into the close, so we’ll want to continue to track NVAX as well.
AEZS, ALSK, NCMI, XGTI, LEXG